Recent transactions
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Jun 8, 2026 | Cannon Gillian | Dir | S Sale | — | $53.14 | $63K | filing |
| Jun 8, 2026 | Patou Gary | Dir | S Sale | — | $53.14 | $70K | filing |
XENON PHARMACEUTICAL (XENE) insider trading activity (SEC Form 4). Over the trailing 90 days, XENE insiders filed 0 purchases totalling $0 and 2 sales totalling $133K — net SELLING of $133K. Most recent filing: Jun 8, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.